Search
for
Sort by
Research 30 of 483
- Comprehensive Case Analysis: Diagnosing and Managing Myositis in Newly Diagnosed Systemic Lupus Erythematosus Patients in Indonesia
- Comprehensive Case Analysis: Diagnosing and Managing Myositis in Newly Diagnosed Systemic Lupus Erythematosus Patients in Indonesia.
- 062 A case of autoimmune facial swelling, weakness and sensorineuropathy with lower limb myositis
- Preclinical efficacy and safety evaluation of a topical mesenchymal stem cell derived conditioned media gel for oral mucositis management
- Associated Variables of Myositis in Systemic Lupus Erythematosus: A Cross-Sectional Study
- Comparison of the therapeutic effects of the dietary and topical forms of Zizyphus jujuba extract on oral mucositis induced by 5-fluorouracil: A golden hamster model
- Decade Long Survey of Low-level Laser Therapy/Photobiomodulation (LLLT/PBM) Therapy for Oral Mucositis Treatment
- Multifunctional Hydrogel with Dual Functions of ROS Scavenging and Responsive Antibiotic Release for Synergistic Oral Mucositis Treatment
- A 39‐year‐old woman with Lupus, Myositis, and a Recalcitrant Vasculopathy
- Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Cutaneous Reactions to Chemotherapeutic Agents
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities
- Acute Bullous Dermatosis and Onycholysis due to High-Dose Methotrexate and Leucovorin Calcium
- Prophylaxis and Management of Skin Toxicities
- Erosive pustular dermatosis of the scalp induced by gefitinib: case and review of the literature
- Mucocutaneous findings in pediatric patients with bone marrow transplantation
- Targeted Treatments of Non-Small Cell Lung Cancer (NSCLC): Skin Toxicity
- Chemotherapy and Cutaneous Drug Reactions
- Manifestaciones dermatológicas en pacientes oncológicos pediátricos en un hospital de tercer nivel de Honduras
- FREQUENCY OF SKIN MANIFESTATIONS IN PATIENTS ON CHEMOTHERAPY
- Alkylating Agents
- Development of PEGylated Liposomes
- Effets secondaires cutanéo-muqueux des nouvelles molécules anticancéreuses: Inhibiteurs de l'EGF-R, inhibiteurs de tyrosine kinase et stabilisateurs du fuseau mitotique
- Clinical expression and morbidity of systemic lupus erythematosus during a post-diagnostic 5-year follow-up: a male:female comparison
- Recurrence of cutaneous T‐cell lymphoma post viral vector COVID‐19 vaccination
- Risk of rhabdomyolysis from 5-α reductase inhibitors